Table 2. Treatment Regimen for HCV Patients along with Treatment Outcomea.
| regimen | duration | genotype | treatment response |
|---|---|---|---|
| SOF | 16/24 weeks | 3 | SVR (n = 23) |
| RVR (n = 18) | |||
| NR/HCC (n = 8) | |||
| SOF/DCV | 12/24 weeks | 3, 1 | SVR (n = 36) |
| RVR (n = 17) | |||
| NR/HCC (n = 6) | |||
| SOF/RBV | 12/24 weeks | 3, 1 | SVR (n = 17) |
| RVR (n = 7) | |||
| SOF/RBV/DCV | 12/24 weeks | 3, 1 | SVR (n = 24) |
| RVR (n = 19) | |||
| NR/HCC (n = 2) |
a
A total of 182 infected individuals received different treatment regimens. The table shows the division of all test individuals depending on the treatment regimen and observed outcomes. Abbreviations: SOF: sofosbuvir, RBV: ribavirin, DCV: daclatasvir, SVR: sustained virologic response, RVR: rapid virologic response, NR: non-responders.